NasdaqGS - Nasdaq Real Time Price USD

SOPHiA GENETICS SA (SOPH)

5.0000 -0.0600 (-1.19%)
As of 3:21 PM EDT. Market Open.
Loading Chart for SOPH
DELL
  • Previous Close 5.0600
  • Open 5.1300
  • Bid 4.9300 x 100
  • Ask 5.0600 x 100
  • Day's Range 4.9600 - 5.1300
  • 52 Week Range 2.1300 - 7.3700
  • Volume 10,164
  • Avg. Volume 59,622
  • Market Cap (intraday) 326.507M
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2200
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.67

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

www.sophiagenetics.com

430

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SOPH

Performance Overview: SOPH

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SOPH
6.16%
S&P 500
6.32%

1-Year Return

SOPH
7.53%
S&P 500
22.69%

3-Year Return

SOPH
--
S&P 500
14.95%

5-Year Return

SOPH
--
S&P 500
14.95%

Compare To: SOPH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SOPH

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    326.51M

  • Enterprise Value

    221.86M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.19

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    3.56

  • Enterprise Value/EBITDA

    -3.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -126.63%

  • Return on Assets (ttm)

    -20.78%

  • Return on Equity (ttm)

    -44.93%

  • Revenue (ttm)

    62.37M

  • Net Income Avi to Common (ttm)

    -78.98M

  • Diluted EPS (ttm)

    -1.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    123.25M

  • Total Debt/Equity (mrq)

    12.28%

  • Levered Free Cash Flow (ttm)

    -31.34M

Research Analysis: SOPH

Analyst Price Targets

8.00
8.67 Average
5.0000 Current
10.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: SOPH

Fair Value

5.0000 Current
 

Dividend Score

0 Low
SOPH
Sector Avg.
100 High
 

Hiring Score

0 Low
SOPH
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
SOPH
Sector Avg.
100 High
 

People Also Watch